210 related articles for article (PubMed ID: 30952761)
1. Exon 9 Mutation of
Seo AN; Kang BW; Bae HI; Kwon OK; Park KB; Lee SS; Chung HY; Yu W; Jeon SW; Kang H; Kim JG
Anticancer Res; 2019 Apr; 39(4):2145-2154. PubMed ID: 30952761
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.
Sukawa Y; Yamamoto H; Nosho K; Kunimoto H; Suzuki H; Adachi Y; Nakazawa M; Nobuoka T; Kawayama M; Mikami M; Matsuno T; Hasegawa T; Hirata K; Imai K; Shinomura Y
World J Gastroenterol; 2012 Dec; 18(45):6577-86. PubMed ID: 23236232
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations.
Böger C; Krüger S; Behrens HM; Bock S; Haag J; Kalthoff H; Röcken C
Ann Oncol; 2017 May; 28(5):1005-1014. PubMed ID: 28453696
[TBL] [Abstract][Full Text] [Related]
4. Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma.
Zhou H; Tan S; Li H; Lin X
Mol Med Rep; 2019 Mar; 19(3):2125-2136. PubMed ID: 30747208
[TBL] [Abstract][Full Text] [Related]
5. [Landscape of KRAS, BRAF, and PIK3CA Mutations and Clinical Features of EBV-Associated and Microsatellite Unstable Gastric Cancer].
Danishevich AM; Pospehova NI; Stroganova AM; Golovina DA; Nikulin MP; Kalinin AE; Nikolaev SE; Stilidi IS; Lyubchenko LN
Mol Biol (Mosk); 2023; 57(1):71-84. PubMed ID: 36976740
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene.
Polom K; Marrelli D; Roviello G; Pascale V; Voglino C; Vindigni C; Generali D; Roviello F
Adv Clin Exp Med; 2018 Jul; 27(7):963-969. PubMed ID: 29905413
[TBL] [Abstract][Full Text] [Related]
7. PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma.
Choi S; Kim H; Heo YJ; Kang SY; Ahn S; Lee J; Kim KM
J Pathol; 2023 Aug; 260(4):443-454. PubMed ID: 37341658
[TBL] [Abstract][Full Text] [Related]
8. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated gastric cancer: disease that requires special approach.
Ignatova E; Seriak D; Fedyanin M; Tryakin A; Pokataev I; Menshikova S; Vakhabova Y; Smirnova K; Tjulandin S; Ajani JA
Gastric Cancer; 2020 Nov; 23(6):951-960. PubMed ID: 32514646
[TBL] [Abstract][Full Text] [Related]
10. Novel Therapeutic Approaches for Epstein-Barr Virus Associated Gastric Cancer.
Kang BW; Baek DW; Kang H; Baek JH; Kim JG
Anticancer Res; 2019 Aug; 39(8):4003-4010. PubMed ID: 31366481
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review.
Harada K; Baba Y; Shigaki H; Ishimoto T; Miyake K; Kosumi K; Tokunaga R; Izumi D; Ohuchi M; Nakamura K; Kiyozumi Y; Kurashige J; Iwatsuki M; Miyamoto Y; Sakamoto Y; Yoshida N; Watanabe M; Baba H
BMC Cancer; 2016 Jul; 16():400. PubMed ID: 27388016
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer.
Kang BW; Seo AN; Yoon S; Bae HI; Jeon SW; Kwon OK; Chung HY; Yu W; Kang H; Kim JG
Ann Oncol; 2016 Mar; 27(3):494-501. PubMed ID: 26673353
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma.
Dong M; Wang HY; Zhao XX; Chen JN; Zhang YW; Huang Y; Xue L; Li HG; Du H; Wu XY; Shao CK
Hum Pathol; 2016 Jul; 53():25-34. PubMed ID: 26980034
[TBL] [Abstract][Full Text] [Related]
14. Associations of
Shen X; Zhao Y; Chen X; Sun H; Liu M; Zhang W; Jiang F; Li P
Future Oncol; 2019 Jun; 15(16):1873-1894. PubMed ID: 30920860
[No Abstract] [Full Text] [Related]
15. Epstein-Barr virus-associated gastric lymphomas are distinct from mucosa-associated lymphoid tissue-type lymphomas: genetic abnormalities of p53 gene.
Chan WY; Chan EK; Chow JH
Diagn Mol Pathol; 2001 Sep; 10(3):153-60. PubMed ID: 11552717
[TBL] [Abstract][Full Text] [Related]
16. PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue.
Yokota T; Serizawa M; Hosokawa A; Kusafuka K; Mori K; Sugiyama T; Tsubosa Y; Koh Y
BMC Cancer; 2018 Aug; 18(1):826. PubMed ID: 30115035
[TBL] [Abstract][Full Text] [Related]
17. Detection of PIK3CA gene mutations with HRM analysis and association with IGFBP-5 expression levels in breast cancer.
Dirican E; Kaya Z; Gullu G; Peker I; Ozmen T; Gulluoglu BM; Kaya H; Ozer A; Akkiprik M
Asian Pac J Cancer Prev; 2014; 15(21):9327-33. PubMed ID: 25422220
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
[TBL] [Abstract][Full Text] [Related]
19.
Byun J; Park NJ; Yoon G; Kang MK; Kim HJ; Park SY; Park JS; Choi GS; Baek JH; Kim JG; Seo AN
Anticancer Res; 2023 Apr; 43(4):1513-1520. PubMed ID: 36974808
[TBL] [Abstract][Full Text] [Related]
20. Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability.
Ma C; Patel K; Singhi AD; Ren B; Zhu B; Shaikh F; Sun W
Am J Surg Pathol; 2016 Nov; 40(11):1496-1506. PubMed ID: 27465786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
